跳至主要内容
临床试验/KCT0002021
KCT0002021招募中未知

Efficacy and Safety of Porcine Placenta Hydrolysate on menopausal symptoms; A 12week, Multi-center, Randomized, Double-blind, Placebo-Controlled Clinical Trial

CellaMedic Korea0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional Study

入排标准

年龄范围
40(Year) 至 60(Year)(—)
性别
All

入选标准

  • 1) kupperman index = 30mm
  • 2) Subject who agrees to participate in the study and signs the informed consent form

排除标准

  • 1) BMI(Body Mass Index) > 30Kg/m2
  • 2) Hormone therapy within the past 3 months
  • 3) Subject with uncontrolled hypertension (over 160/100mmHg, when measuring after 10 minutes steady)
  • 4) Subject with uncontrolled diabetes mellitus (more than 180mg/dl of fasting glucose)
  • 5) History of drug abuse, or alcoholism
  • 6) Subject with AST(GOT) or ALT(GPT) or ?-GTP = 3 times the upper limit of normal
  • 7) Subject with serum creatinine = 2 times the upper limit of normal
  • 8) Subject who participated in any clinical trial within 1 month or plan to participate in the other clinical study
  • 9) Inappropriate subject decided by the investigator

研究者

发起方
CellaMedic Korea

相似试验